PlainPharmaWatch

CMS Open Payments · Program Year 2024

Genmab BV

Genmab BV reported $357,675.58 across General Payments, Research, and Ownership to 4 physicians and teaching hospitals across 77 transactions.

See the rankings → How this is sourced
$357.7K
All-tracks total
77
Transactions
4
Recipients
#854
of 1,925 companies

Genmab BV reported $357,675.58 across all CMS Open Payments tracks (General + Research + Ownership) to 4 physicians and teaching hospitals in Program Year 2024 - ranking #854 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $51,500.00, averaging $89.4K per recipient.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the publisher.

CMS Sunshine Act warrant

Manufacturer genmab-bv Genmab BV

$357.7K · #854/1,925 · 0.0% industry · PY2024

  • TOT $357.7K
  • RANK #854
  • SHARE 0.0%
  • TXN 77
  • RCP 4
  • CAT 1
  • GEN $51.5K
  • TOP1 56.3%
  • PY 2024

Volume peers

Nearest volume peer: Ossio Inc ($357.9K)

Heidelberg Engineering, Inc.$361.5KOssio Inc$357.9KGenmab BV (this)$357.7KSOMAVAC Medical Solutions, I…$354.1KUCB GmbH$354.0K
All-tracks payment totals near Genmab BV (CMS Open Payments PY2024)

Genmab BV sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →

What the Data Shows for Genmab BV

$357,675.58: that is what Genmab BV reported in payments to 4 physicians and teaching hospitals during Program Year 2024, spread across 77 transactions ($4.6K per transaction, $89.4K per recipient). The company sits at rank #854 of 1,925, a comparatively small 0.0% slice of all industry payments reported nationwide for the year.

"Compensation for Services Other Than Consulting" leads the 1-category general-payment breakdown below at $51.5K (100.0% of General Payments, 4 transactions) - see our methodology for how research and ownership payments are reported separately.

General Payment Breakdown by Type

Across 1 types of general payments, Genmab BV's largest category was "Compensation for Services Other Than Consulting" at $51.5K - 100.0% of General Payments.

How Genmab BV divides its payments

How the reported total splits across payment categories

1. Compensation for Services…$51.5K
Payment Type Amount Transactions
Compensation for Services Other Than Consulting $51.5K 4

Recipient Concentration in General Payments

The five largest recipient relationships account for $51,500.00 (100.0%) of $51,500.00 in this company's General Payments records across 2 recipients.

General Payments scope note

Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for Genmab BV

The five named recipients with the highest reported General Payments from this company

Ut Md Anderson Cancer Center$29.0KUniversity Of Washington Med…$22.5K
  1. 1

    Ut Md Anderson Cancer Center

    $29,000.00 across 3 reported transactions

  2. 2

    University Of Washington Med Ctr

    $22,500.00 across 1 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Similarly Concentrated Companies

Companies whose General Payments are spread across recipients about as (un)evenly as Genmab BV's, measured by the same HHI concentration index above, not by payment size.

What HHI 2,500 means here

2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Genmab BV.

Amnio Technology, LLC

HHI 5078

New Age Medical LLC

HHI 5077

Strategic Dentistry LLC

HHI 5083

Infinity BiologiX LLC

HHI 5072

Companies with Similar Payment Volumes

Open a profile or compare a similar company's CMS-reported payment pattern with Genmab BV.

Showing 6 of 1,924 companies with CMS-reported payment data.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download Genmab BV's data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.